Q2 2025 13F Holders as of 30 Jun 2025
-
Type / Class
-
Equity / COMMON STOCK
-
Shares outstanding
-
163,926,065
-
Total 13F shares
-
128,553,808
-
Share change
-
+6,583,762
-
Total reported value
-
$1,223,875,095
-
Put/Call ratio
-
204%
-
Price per share
-
$9.52
-
Number of holders
-
195
-
Value change
-
+$58,226,785
-
Number of buys
-
117
-
Number of sells
-
83
Institutional Holders of Dyne Therapeutics, Inc. - COMMON STOCK (DYN) as of Q2 2025
As of 30 Jun 2025 Dyne Therapeutics, Inc. - COMMON STOCK (DYN) had 195 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 128,553,808 shares of stock of the company.
Largest 10 holders included RA CAPITAL MANAGEMENT, L.P., JANUS HENDERSON GROUP PLC, Atlas Venture Life Science Advisors, LLC, BlackRock, Inc., VANGUARD GROUP INC, FCPM III SERVICES B.V., FMR LLC, Siren, L.L.C., TCG Crossover Management, LLC, and STATE STREET CORP.
This table shows 195 institutional shareholders of the security as of 30 Jun 2025.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.